Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the fields of human genetics, chromosome structure and function.

Contact Details: Tel: Fax: Email: WWW: www.athersys.com/

Recent Publications by Athersys Incorporated:
Therapeutic pathways of adult stem cell repair. The use of adult stem cells as therapeutic agents to treat disease has...	4th April, 2008	Division of Regenerative Medicine, Athersys Inc., 3201 Carnegie Avenue,	Crit Rev Oncol Hematol. 2008 Jan;65(1):81-93. Epub 2007 Nov 26. DOI Direct Link
Development of adult pluripotent stem cell therapies for ischemic injury and disease. Over the past 5 years, adult pluripotent stem cell lines have been...	27th June, 2007	Athersys, Inc., Division of Regenerative Medicine, 3201 Carnegie Avenue,	Expert Opin Biol Ther. 2007 Feb;7(2):173-84. DOI Direct Link
Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes. The serotonin (5-hydroxytryptamine) 5-HT2 receptor subfamily consists of...	21st December, 2006	Athersys, Inc., Cleveland, OH 44115, USA.	Assay Drug Dev Technol. 2005 Dec;3(6):649-59. DOI Direct Link
Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel. Introduction: The hERG (human ether-a-go-go related gene) potassium...	13th October, 2006	Athersys, Inc., 3201 Carnegie Avenue, Cleveland, OH 44115, USA.	J Pharmacol Toxicol Methods. 2006 Jul-Aug;54(1):42-55. Epub 2005 Dec 2. DOI Direct Link
The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist. 5-HT2C agonists have shown efficacy in limiting food consumption and thus...	12th September, 2006	Athersys, Inc., 3201 Carnegie Ave., Cleveland, OH 44115, USA.	Bioorg Med Chem Lett. 2006 Aug 1;16(15):4130-4. Epub 2006 Jun 5. DOI Direct Link
→View more Athersys Incorporated research publications.

BioNews Results for Athersys Incorporated:
Athersys Reports 2009 Third Quarter Results	Individual.com:  Nov 5 2009 11:53PM Matching: athersys
Athersys Reports 2009 Third Quarter Results	Therapeutics Daily:  Nov 5 2009 10:41PM Matching: athersys
Athersys to Host Third Quarter 2009 Financial Results Call	Individual.com:  Oct 20 2009 3:08PM Matching: athersys

Athersys Incorporated Clinical Trials:
Safety Study of AMI MultiStem® to Treat Heart Attacks

Athersys Incorporated Patents:
US Patent No.	Title
7528262	Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
6410266	Compositions and methods for non-targeted activation of endogenous genes
6524818	Compositions and methods for non-targeted activation of endogenous genes
6524824	Compositions and methods for non-targeted activation of endogenous genes
6541221	Compositions and methods for non-targeted activation of endogenous genes
→View more Athersys Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 326 times since April 2007, the link to the organisation's website has been followed 54 times

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Athersys Incorporated